Indian Drug Makers Fret Government Not Up To Speed On Glivec Suit
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers contend government officials are not being briefed properly about the Supreme Court case involving a challenge to a Novartis patent for Glivec (imatinib) for treating blood cancer